全文获取类型
收费全文 | 1278298篇 |
免费 | 95198篇 |
国内免费 | 1989篇 |
专业分类
耳鼻咽喉 | 18268篇 |
儿科学 | 42438篇 |
妇产科学 | 38021篇 |
基础医学 | 186985篇 |
口腔科学 | 35514篇 |
临床医学 | 108847篇 |
内科学 | 251556篇 |
皮肤病学 | 26557篇 |
神经病学 | 99583篇 |
特种医学 | 50234篇 |
外国民族医学 | 367篇 |
外科学 | 198169篇 |
综合类 | 26749篇 |
现状与发展 | 1篇 |
一般理论 | 309篇 |
预防医学 | 93122篇 |
眼科学 | 29106篇 |
药学 | 98310篇 |
1篇 | |
中国医学 | 2443篇 |
肿瘤学 | 68905篇 |
出版年
2018年 | 11963篇 |
2015年 | 11780篇 |
2014年 | 16216篇 |
2013年 | 24696篇 |
2012年 | 33982篇 |
2011年 | 36388篇 |
2010年 | 21473篇 |
2009年 | 20275篇 |
2008年 | 35353篇 |
2007年 | 38415篇 |
2006年 | 38946篇 |
2005年 | 38224篇 |
2004年 | 36760篇 |
2003年 | 35676篇 |
2002年 | 35236篇 |
2001年 | 58346篇 |
2000年 | 59764篇 |
1999年 | 50686篇 |
1998年 | 13590篇 |
1997年 | 12136篇 |
1996年 | 12388篇 |
1995年 | 12385篇 |
1994年 | 11823篇 |
1993年 | 10912篇 |
1992年 | 41182篇 |
1991年 | 40597篇 |
1990年 | 40045篇 |
1989年 | 38880篇 |
1988年 | 36275篇 |
1987年 | 35528篇 |
1986年 | 33873篇 |
1985年 | 32284篇 |
1984年 | 24044篇 |
1983年 | 20916篇 |
1982年 | 12424篇 |
1981年 | 10959篇 |
1980年 | 10224篇 |
1979年 | 22725篇 |
1978年 | 15953篇 |
1977年 | 13767篇 |
1976年 | 13022篇 |
1975年 | 14247篇 |
1974年 | 16759篇 |
1973年 | 16175篇 |
1972年 | 15395篇 |
1971年 | 14299篇 |
1970年 | 13278篇 |
1969年 | 12800篇 |
1968年 | 12055篇 |
1967年 | 10520篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
41.
42.
43.
44.
45.
Fráter Márk Sáry Tekla Molnár Janka Braunitzer Gábor Lassila Lippo Vallittu Pekka K. Garoushi Sufyan 《Clinical oral investigations》2022,26(4):3501-3513
Clinical Oral Investigations - The aim of this in vitro study was to investigate the fatigue survival and fracture behavior of endodontically treated (ET) premolars restored with different types of... 相似文献
46.
47.
Moreira Daniel C. Venkataraman Sujatha Subramanian Apurva Desisto John Balakrishnan Ilango Prince Eric Pierce Angela Griesinger Andrea Green Adam Eberhardt Charles G. Foreman Nicholas K. Vibhakar Rajeev 《Journal of neuro-oncology》2020,147(3):531-545
Journal of Neuro-Oncology - MYC-driven medulloblastomas are highly aggressive childhood tumors with dismal outcomes and a lack of new treatment paradigms. We identified that targeting replication... 相似文献
48.
Michael T Milano Veronica L S Chiang Scott G Soltys Tony J C Wang Simon S Lo Alexandria Brackett Seema Nagpal Samuel Chao Amit K Garg Siavash Jabbari Lia M Halasz Melanie Hayden Gephart Jonathan P S Knisely Arjun Sahgal Eric L Chang 《Neuro-oncology》2020,22(12):1728
BackgroundThe American Radium Society (ARS) Appropriate Use Criteria brain malignancies panel systematically reviewed (PRISMA [Preferred Reporting Items for Systematic Reviews and Meta-Analyses]) published literature on neurocognitive outcomes after stereotactic radiosurgery (SRS) for patients with multiple brain metastases (BM) to generate consensus guidelines.MethodsThe panel developed 4 key questions (KQs) to guide systematic review. From 11 614 original articles, 12 were selected. The panel developed model cases addressing KQs and potentially controversial scenarios not addressed in the systematic review (which might inform future ARS projects). Based upon quality of evidence, the panel confidentially voted on treatment options using a 9-point scale of appropriateness.ResultsThe panel agreed that SRS alone is usually appropriate for those with good performance status and 2–10 asymptomatic BM, and usually not appropriate for >20 BM. For 11–15 and 16–20 BM there was (between 2 case variants) agreement that SRS alone may be appropriate or disagreement on the appropriateness of SRS alone. There was no scenario (among 6 case variants) in which conventional whole-brain radiotherapy (WBRT) was considered usually appropriate by most panelists. There were several areas of disagreement, including: hippocampal sparing WBRT for 2–4 asymptomatic BM; WBRT for resected BM amenable to SRS; fractionated versus single-fraction SRS for resected BM, larger targets, and/or brainstem metastases; optimal treatment (WBRT, hippocampal sparing WBRT, SRS alone to all or select lesions) for patients with progressive extracranial disease, poor performance status, and no systemic options.ConclusionsFor patients with 2–10 BM, SRS alone is an appropriate treatment option for well-selected patients with good performance status. Future study is needed for those scenarios in which there was disagreement among panelists. 相似文献
49.
Hallet Julie Look Hong Nicole J. Zuk Victoria Davis Laura E. Gupta Vaibhav Earle Craig C. Mittmann Nicole Coburn Natalie G. 《Gastric cancer》2020,23(3):373-381
Gastric Cancer - Esophagogastric cancer (EGC) is one of the deadliest and costliest malignancies to treat. Care by high-volume providers can provide better outcomes for patients with EGC. Cost... 相似文献